Skip to main content
Fig. 8 | Journal of Nanobiotechnology

Fig. 8

From: A chitosan-based cascade-responsive drug delivery system for triple-negative breast cancer therapy

Fig. 8

Biosafety data from in vivo studies after treatment for 30 days. a H&E analysis of the major organs (yellow arrows indicate cell necrosis, scale bars = 100 μm). b Concentrations of key biomarkers for side effects. Left histogram: serum hepatic function indices; right histogram: serum renal function indices. *P < 0.05, **P < 0.01 as compared to the saline group. Data are given as mean ± S.D (n = 6)

Back to article page